申请人:Kallus Christopher
公开号:US20140206760A1
公开(公告)日:2014-07-24
The invention relates to compounds of the formula (I) which are inhibitors of activated thrombin-activable fibrinolysis inhibitor. The compounds of the formula I are suitable for producing medicaments for prophylaxis, secondary prevention and treatment of one or more disorders associated with thromboses, embolisms, hypercoaguability or fibrotic changes.
本发明涉及公式(I)的化合物,其为激活的凝血酶可激活纤溶抑制剂的抑制剂。公式I的化合物适用于生产用于预防、次级预防和治疗与血栓、栓塞、高凝状态或纤维化变化有关的一个或多个疾病的药物。